Dopaminergic modulation of the trade-off between probability and time in economic decision-making
Introduction
Reports on animals and humans have established the importance of the dopaminergic system in reward-encoding and decision-making processes. Studies on macaques have shown that neurons capable of encoding value-related elements are located in the striatum (Lau and Glimcher, 2008, Samejima et al., 2005). In humans, the striatum is not only active during the evaluation of the primary reward characteristics (Knutson et al., 2007, McClure et al., 2007) but it also encodes subjective value (De Martino et al., 2009, Hsu et al., 2009, Kable and Glimcher, 2007). Dopaminergic treatment used in Parkinson׳s disease (PD) induces impulsivity among other adverse effects (Ceravolo et al., 2010, Merims and Giladi, 2008). The modification of dopamine levels in PD patients with impulse control disorders (ICD) has been associated with a devaluation of a delayed reward (Voon et al., 2010). The acute administration of levodopa to healthy controls had an effect on reward-related behavior, predisposing subjects to select shorter delay options although, the administration of a dopamine antagonist, haloperidol, did not produce significant behavioral changes (Pine et al., 2010). Previous work has also shown that acute administration of dopamine antagonists effectively modified reward related behaviors such as gambling (Tremblay et al., 2010) and instrumental learning (Eisenegger et al., 2014, Pessiglione et al., 2006). In rats decision-making under uncertainty was influenced by a striatal D2/3 receptor antagonist, increasing risk aversion (Cocker et al., 2012, St Onge and Floresco, 2009). A proposed mechanism for these effects has been to consider dopamine a neurotransmitter driving motivation towards rewards (Berridge et al., 2009). Use of different dopamine antagonists in decision-making paradigms may help to further unravel the role of dopamine in reward related human behaviors.
A choice often involves both the passage of time before an outcome is reached and uncertainty regarding the outcome. Examples are investment decisions that lead to uncertain payoffs in the future, or consumption decisions that involve comparing alternative paths with different delays and uncertain gratification. However, most studies in the field of economics have focused on the study of the trade-off between reward magnitude and probability, and between reward magnitude and delay separately. Reflections on the primacy of time or probability discounting have been mainly based on parallels in the trade-off between reward magnitude and probability, and reward magnitude and delay; for a review see Berns et al. (2007). In this work, we aimed to elucidate which brain areas are involved during the decision-making process when both delay and risk are being concurrently evaluated. Aside from the intrinsic increase in value when a reward is received with higher probability, which can thus be traded against an increase in delay, a trade-off between delay and risk is central in many instances of decision making in modern society. Fields where a trade-off between time and probability of reward is needed when making decisions include project management where more time intensive procedures may increase the probability of success of a project, in environmental economics where more time consuming applications of policy decisions can modify the chances of obtaining the desired outcome and in health economics where the length of treatments can influence the probability of a preferred outcome. This kind of interaction between time and risk in decision making is also in line with classical foraging theory models in which the probability of a reward is weighted against the effort or time required for an animal to obtain it (Real and Caraco, 1986).
To shed light on the role of dopamine in the trade-off between probability and delay, we measured the impact of a dopamine D2 receptor (D2R) antagonist, metoclopramide, on the behavioral and functional outcome of a probability-time trade-off paradigm, using functional magnetic resonance imaging (fMRI). Metoclopramide, a derivative of benzamide, acts by antagonizing the dopamine D2 receptor in the peripheral and central nervous systems, as it easily crosses the blood brain barrier (Liu et al., 2009). Its short-term-use good safety profile (Friedman et al., 2011) and short lasting effect led us to consider it as an interesting D2R antagonist. In addition, we have previously demonstrated that a single dose of metoclopramide is capable of altering cerebral perfusion in humans (Fernandez-Seara et al., 2011).
We hypothesized that the administration of metoclopramide would increase the willingness of subjects to wait for a less risky reward (i.e. a reward with higher probability), when compared to the administration of placebo. It was also expected that medication would modify activity in striatal regions, which present the highest density of D2Rs, or in frontal regions involved in decision-making. The VMOFC has been proposed to be a key region in the valuation of rewards and hence was considered a priori a key area to search for activations related to the assignation of subjective value and the difference in this assessment between groups (Bartra et al., 2013, Levy and Glimcher, 2012).
Section snippets
Subjects
Two groups of subjects were evaluated, in a single-blind, placebo controlled study. The medicated group (MG) consisted of 15 subjects, six females (age=24.0±3.4 years: mean±standard deviation (SD)), who received an oral dose (10 mg) of metoclopramide (commercial name Primperan) one hour prior to entering the scanner. The pharmacokinetic properties of the drug are included in Supplementary material. The second group followed the same experimental procedure, but taking a placebo (an identical
Behavioral measures
Individual behavioral measures in the placebo and the medicated groups (PG and MG respectively) were used to evaluate possible differences at the group level in terms of consistency, response time and level of attention.
The PG and MG group median consistency of the responses was 94% (range 83–100%, SD=5). Statistical differences (p=0.029) were found between PG (median(range):92(83–100)) and MG (median(range):98(83–99)). MG showed higher consistency in reproducing the same answer in each of the
Discussion
The administration of a single dose of metoclopramide, a D2R antagonist, to healthy volunteers led to behavioral and brain activity changes during a decision-making task. Behaviorally, medicated subjects presented less modulation in their choices. They preferred the most delayed option in the majority of the configurations, showing a reduced influence of increasing delay on their final choice when compared to PG. Our study is the first to describe a differential effect of dopamine in
Role of the funding source
The sponsors of the study had no role in the design, analysis, interpretation, or writing of the report. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.
Contributors
Maria A. Pastor and Franz H. Heukamp designed the study.
Maite Aznárez-Sanado, Maria A. Fernández-Seara and Maria A. Pastor prepared and optimized the MRI protocol.
Maite Aznárez-Sanado, Maria A. Fernández-Seara, Francis R. Loayza, Ewa Salamon-Klobut and Maria A. Pastor collected the data.
Maite Aznárez-Sanado, Maria A. Fernández-Seara, Gonzalo Arrondo and Maria A. Pastor processed the neuroimaging data. Maite Aznárez-Sanado, Gonzalo Arrondo, Joaquín Goñi and Franz H. Heukamp processed the
Conflict of interest
The authors do not have any conflict of interest.
Acknowledgments
This work was funded by the Foundation for Applied Medical Research (FIMA, University of Navarra) and a grant from EUROCORES (the European Science Foundation). M. A-S was a Government of Navarra Predoctoral Fellow (2007-2010).
References (51)
- et al.
The valuation system: a coordinate-based meta-analysis of BOLD fMRI experiments examining neural correlates of subjective value
Neuroimage
(2013) - et al.
Intertemporal choice--toward an integrative framework
Trends Cogn. Sci.
(2007) - et al.
Dissecting components of reward: ׳liking׳, ׳wanting׳, and learning
Curr. Opin. Pharmacol.
(2009) - et al.
Assignment of functional activations to probabilistic cytoarchitectonic areas revisited
Neuroimage
(2007) - et al.
The structural and functional connectivity of the amygdala: from normal emotion to pathological anxiety
Behav. Brain Res.
(2011) - et al.
Neural predictors of purchases
Neuron
(2007) - et al.
Value representations in the primate striatum during matching behavior
Neuron
(2008) - et al.
The root of all value: a neural common currency for choice
Curr. Opin. Neurobiol.
(2012) - et al.
Dopamine dysregulation syndrome, addiction and behavioral changes in Parkinson׳s disease
Parkinsonism Relat. Disord.
(2008) - et al.
Cerebral morphology and dopamine D2/D3 receptor distribution in humans: a combined [18F]fallypride and voxel-based morphometry study
Neuroimage
(2009)
Probability and Time Trade-off
Manag. Sci.
Methamphetamine-induced disruption of frontostriatal reward learning signals: relation to psychotic symptoms
Am. J. Psychiatry
Dopaminergic network differences in human impulsivity
Science
Spectrum of addictions in Parkinson׳s disease: from dopamine dysregulation syndrome to impulse control disorders
J Neurol
Antipsychotic drug binding in the substantia nigra: an examination of high metoclopramide binding in the brains of normal, Alzheimer׳s disease, Huntington׳s disease, and Multiple Sclerosis patients, and its relation to tardive dyskinesia
Synapse
A psychobiological model of temperament and character
Arch. Gen. Psychiatry
Irrational choice under uncertainty correlates with lower striatal D(2/3) receptor binding in rats
J. Neurosci.
Effect of basal conditions on the magnitude and dynamics of the blood oxygenation level-dependent fMRI response
J. Cereb. Blood Flow. Metab.: Off. J. Int. Soc. Cereb. Blood Flow. Metab.
Inverted-U-shaped dopamine actions on human working memory and cognitive control
Biol. Psychiatry
How do you feel--now? The anterior insula and human awareness
Nat. Rev. Neurosci.
The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia
Neurology
The neurobiology of reference-dependent value computation
J. Neurosci.
Role of Dopamine D2 receptors in human reinforcement learning
Neuropsychopharmacology
Cited by (15)
Toward a Unifying Account of Dopamine's Role in Cost-Benefit Decision Making
2023, Biological Psychiatry Global Open ScienceDelay discounting in Parkinson's disease: A systematic review and meta-analysis
2023, Behavioural Brain ResearchCitation Excerpt :A recent systematic review and meta-analysis [24] on rats documented a reduced DD following the exposure to dopamine transporter-modulating drugs, while the exposure to D1-like and D2-like receptors antagonist increased discounting. This is in contrast with the study by Arrondo et al. [8] on healthy humans, showing that the administration of metoclopramide, a D2-like receptor antagonist, reduces DD making them more prone to postpone a reward to increase its value. Finally, the literature documents that D2/like (D2/D3) dopaminergic agonists, such as pramipexole and ropinirole, increase DD in rats, non-human primates, and humans (e.g., [79,81]).
Using pharmacological manipulations to study the role of dopamine in human reward functioning: A review of studies in healthy adults
2021, Neuroscience and Biobehavioral ReviewsCitation Excerpt :Consistent with null results for probability discounting tasks and DA augmentation, two studies using probability discounting paradigms with DA reduction also showed null results. The first, Arrondo et al. (2015) was discussed previously under delay discounting, as in this study delay was confounded with probability. Computational modeling of this task indicated that metoclopramide (10 mg) affected delay, but not probability parameters.
Neural correlates of effort-based behavioral inconsistency
2019, CortexCitation Excerpt :Thus, every decision is a trade-off between costs and benefits where the agent decides the convenience of selecting an expected outcome or doing an action. SV can be computed as the objective expected reward multiplied by the subjective discounting rate (ranging from 0 to 1) of the corresponding devaluating factor (time, risk or effort) (see, for example, Arrondo et al., 2015; Bernacer et al., 2016; Green & Myerson, 2004; Kable & Glimcher, 2007; Peters & Büchel, 2010). It is widely accepted that activity in ventromedial regions of the prefrontal cortex correlates with SV of the chosen option (Levy & Glimcher, 2012); beside this, other regions are involved in SV comparison when two options are presented, such as the posterior cingulate (Bartra, McGuire, & Kable, 2013; FitzGerald, Seymour, & Dolan, 2009) and dorsomedial prefrontal cortex (Rushworth, Kolling, Sallet, & Mars, 2012).
An fMRI study of decision-making under sunk costs in gambling disorder
2018, European NeuropsychopharmacologyCitation Excerpt :Accordingly, an improved understanding of the neural basis of altered decision making abilities under sunk costs could provide useful information when developing behavioral interventions for this patient group. Recently, our understanding of how decision making is implemented in the brain has grown rapidly (Arrondo et al., 2015; Chib et al., 2012; Dias et al., 2013; Fujino et al., 2017; Helmbold et al., 2015; Kambeitz et al., 2016; Macoveanu et al., 2013; Mobbs et al., 2013; Takahashi et al., 2012; Tei et al., 2014, 2017; Zack et al., 2016). Previous functional magnetic resonance imaging (fMRI) studies on healthy subjects have revealed that several brain regions, including the medial prefrontal cortex (MPFC), inferior frontal gyrus (IFG), anterior cingulate cortex (ACC), insula, and amygdala, play key roles in decision making under sunk costs (Zeng et al., 2013; Haller and Schwabe, 2014; Fujino et al., 2016a).
Brain correlates of the intrinsic subjective cost of effort in sedentary volunteers
2016, Progress in Brain ResearchCitation Excerpt :The engagement of VMPFC in value coding has been verified by extensive research (see, for example, Bartra et al., 2013; Dreher, 2013; Montague et al., 2006; O’Doherty, 2011). Pharmacologically, this valuation seems to depend on monoaminergic signaling (Arrondo et al., 2015; Bernacer et al., 2013; Jocham et al., 2011). In the following paragraphs, we briefly summarize the main findings about intrinsic subjective costs in decision making in the fields of psychology and neuroscience.
- 1
These authors have contributed equally.